{
    "title": "Roche sees slowdown in COVID-driven sales growth",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10750835/Roche-sees-slowdown-COVID-driven-sales-growth.html",
    "date": "2022-04-25",
    "keywords": [
        "growth",
        "covid19",
        "roche",
        "cancer",
        "burger",
        "demand",
        "scenario",
        "decline",
        "trial",
        "antigen",
        "specialty",
        "drugmaker",
        "drop",
        "executive",
        "severin",
        "schwan",
        "covid",
        "antibody",
        "treatment",
        "course",
        "upside",
        "winter",
        "season",
        "planning",
        "call",
        "monday",
        "year",
        "period",
        "market",
        "consensus",
        "division",
        "surprise",
        "reporting",
        "usage",
        "boost",
        "ocrevus",
        "sclerosis",
        "hemlibra",
        "percentage",
        "range",
        "gain",
        "revenue",
        "offpatent",
        "avastin",
        "rituxan",
        "gmt",
        "performance",
        "stoxx",
        "health",
        "care",
        "index",
        "immunetherapy",
        "tecentriq",
        "drug",
        "candidate",
        "giredestrant",
        "type",
        "breast",
        "disease",
        "progression",
        "midstage",
        "programme",
        "sanofi",
        "month",
        "development",
        "setback",
        "class",
        "response",
        "astrazeneca",
        "option",
        "standard",
        "miranda",
        "murray",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}